These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1096 related articles for article (PubMed ID: 276347)

  • 1. Endolymphatic isotope and BCG in the management of malignant melanoma.
    Edwards JM; Pheils PJ
    Aust N Z J Surg; 1978 Feb; 48(1):40-8. PubMed ID: 276347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Radiation therapy of malignant melanoma (author's transl)].
    Scherer E; Makoski HB
    Langenbecks Arch Chir; 1976 Nov; 342():545-8. PubMed ID: 825693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vitality evaluation of malignant melanoma metastases following endolymphatic radionuclide therapy using the Falck-Hillarp method].
    Paul E; Illig L; Möller W
    Hautarzt; 1975 Jun; 26(6):317-20. PubMed ID: 1165195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endolymphatic BCG therapy in the rabbit VX2 tumor.
    Edwards JM; O'Donnell TF; Johnson H; Rutt D; Kinmonth JB
    Surg Forum; 1975; 26():147-9. PubMed ID: 1216093
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical results of endolymphatic radionuclide therapy in the treatment of malignant melanoma].
    Makoski HB; Magnus L; Heissen E; Kolpatzik H; Drepper H
    Strahlentherapie; 1974 Jul; 148(1):1-15. PubMed ID: 4612879
    [No Abstract]   [Full Text] [Related]  

  • 6. A clinical trial of endolymphatic therapy in malignant melanoma: interim report of the progress of the Medical Research Council trial.
    Br J Surg; 1979 Jan; 66(1):9-13. PubMed ID: 369645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endolymphatic radionuclide therapy of the malignant melanoma (author's transl)].
    Makoski HB; Scherer E; Magnus L; Verbeek W
    Strahlentherapie; 1978 Mar; 154(3):169-73. PubMed ID: 635942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathomorphosis of metastatic malignant melanoma of the skin as effected by preoperative endolymphatic polychemotherapy].
    Naleskina LA; Tolstopiatov BA; Korovin SI
    Klin Khir (1962); 1993; (5):27-30. PubMed ID: 7933857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Endolymphatic lipiodol-P32 therapy in melanoma of the limbs during clinical stage 1].
    Kokoschka E
    Med Welt; 1974 Jun; 25(23):1054-5. PubMed ID: 4369551
    [No Abstract]   [Full Text] [Related]  

  • 10. [Endolymphatic radionuclide adjuvant therapy of melanoma and its side effects on the cellular immune system].
    Richter G; Heidenbluth I; Heidelbach U
    Dermatol Monatsschr; 1982 Dec; 168(12):797-806. PubMed ID: 7169101
    [No Abstract]   [Full Text] [Related]  

  • 11. Prophylactic intralymphatic isotope therapy.
    Mott TJ
    Proc R Soc Med; 1973 Dec; 66(12):1238-9. PubMed ID: 4777059
    [No Abstract]   [Full Text] [Related]  

  • 12. Current status of endolymphatic therapy with radionuclides.
    Peters PE; Weissleder H
    Lymphology; 1974 Mar; 7(1):49-52. PubMed ID: 4851228
    [No Abstract]   [Full Text] [Related]  

  • 13. Preliminary results of a randomized trial of adjuvant immunotherapy in patients with malignant melanoma who have lymph node metastases.
    Morton DL; Eilber FR; Holmes EC; Ramming KP
    Aust N Z J Surg; 1978 Feb; 48(1):49-52. PubMed ID: 276348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of treating malignant melanoma intralymphatically with radioactive isotopes.
    Ariel IM
    Surg Gynecol Obstet; 1974 Nov; 139(5):726-30. PubMed ID: 4372734
    [No Abstract]   [Full Text] [Related]  

  • 15. Adjuvant BCG immunotherapy for stage I and II malignant melanoma.
    Silver HK; Ibrahim EM; Evers JA; Thomas JW; Murray RN; Spinelli JJ
    Can Med Assoc J; 1983 Jun; 128(11):1291-5. PubMed ID: 6342739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention and treatment of regional lymphatic metastasis of cutaneous melanoma].
    Korovin SI; Tolstopiatov BA
    Klin Khir (1962); 1993; (5):34-6. PubMed ID: 7933861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined BCG and irradiation treatment of skin metastases originating from malignant melanoma.
    Plesnicar S; Rudolf Z
    Cancer; 1982 Sep; 50(6):1100-6. PubMed ID: 7104950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of adjuvant therapy in patients with metastasis of melanoma to regional lymph nodes].
    Korovin SI
    Klin Khir; 1998; (2):22-3. PubMed ID: 9615073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant immunotherapy with BCG in treatment of regional-lymph-node metastases from malignant melanoma.
    Eilber FR; Morton DL; Holmes EC; Sparks FC; Ramming KP
    N Engl J Med; 1976 Jan; 294(5):237-40. PubMed ID: 1244548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant reactivity predicts survival in patients with "high-risk" primary malignant melanoma treated with systemic BCG. EORTC Malignant Melanoma Cooperative Group Writing Committee.
    Cochran AJ; Buyse ME; Lejeune FJ; Macher E; Revuz J; Rümke P
    Int J Cancer; 1981 Nov; 28(5):543-50. PubMed ID: 7309294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.